Home

Market Capitalization of Cohance Lifesciences Ltd

Image

Cohance Lifesciences Ltd

NSE: COHANCE

Market Cap

₹ 37711.56 crore

Last updated on: Jul 09, 2025

Key Highlights

  • The Market Cap of Cohance Lifesciences Ltd is ₹ 37711 crore as of 09 Jul 25 .
  • The Latest Trading Price of Cohance Lifesciences Ltd is ₹ 985.75 as of 09 Jul 15:30 .
  • The Dividend Payouts of Cohance Lifesciences Ltd changed from ₹ 2 on Feb 15, 2022 to ₹ 1 on Sep 09, 2022 . This represents a CAGR of -10.91% over 6 years.
Image

Cohance Lifesciences Ltd

NSE: COHANCE

Share Price

₹ 985.75

-4.70 (-0.47%)

stock direction

Last updated on: Jul 09, 2025

Market Price of Cohance Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Cohance Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Jul 2025985.75
08 Jul 2025990.45
07 Jul 20251018.75
04 Jul 20251043.8
03 Jul 20251006.65
02 Jul 2025967.4
01 Jul 2025960.35
30 Jun 2025966.65
27 Jun 2025944.05
26 Jun 20251002.1

SWOT Analysis Of Cohance Lifesciences Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Cohance Lifesciences Ltd

Asset Value vs Market Value of Cohance Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Cohance Lifesciences Ltd

No data available

No data available

Historical P/E Ratio of Cohance Lifesciences Ltd

No data available

* All values are in %

Historical Revenue of Cohance Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Cohance Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Cohance Lifesciences Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Cohance Lifesciences Ltd

No data available

* All values are in

About Cohance Lifesciences Ltd

  • Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
  • The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Suven Pharmaceuticals Limited was incorporated on 6 November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
  • The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles.

Cohance Lifesciences Ltd News Hub

Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter

Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024

Read more

09 Aug 24

Suven Pharmaceuticals to hold board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 August 2024.

Read more

06 Aug 24

Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman

Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chairman, effec

Read more

19 Sept 24

Board of Suven Pharmaceuticals approves change in Executive Chairperson

The Board of Suven Pharmaceuticals at its meeting held on 19 September 2024 has taken on record the

Read more

19 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Cohance Lifesciences Ltd Market Cap

What is the market cap of Cohance Lifesciences Ltd?

As of July 10, 2025, Cohance Lifesciences Ltd has a market capitalization of ₹37711.56, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Cohance Lifesciences Ltd's market capitalization?

Cohance Lifesciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Cohance Lifesciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Cohance Lifesciences Ltd's market capitalization change?

Cohance Lifesciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions